Navigation Links
Oncology remains most restrictive specialty for second year
Date:7/30/2013

EVANSTON, Ill., July 30, 2013 /PRNewswire/ -- Oncology remains the most restrictive specialty for pharmaceutical sales representative access this year for the second year in a row. This according to the spring 2013 AccessMonitor™ report from global consulting firm ZS Associates.

The report found that about 65 percent of oncologists in the United States placed moderate-to-severe restrictions on visits from pharmaceutical sales reps. By comparison, about 58 percent of cardiologists and 47 percent of primary care physicians restrict rep access to the same degree. Oncology is the most restrictive of the 20 common medical specialties measured in the report. By comparison, only 17 percent of oncologists restricted access to reps in 2008.

"Today, the average rep can see an oncologist only seven or eight times per year – and even the best reps visit oncologists just once per month," said Ganesh Vedarajan, principal and leader of the oncology and specialty therapeutics practice at ZS Associates. "Access has continued to decline due to an increased number of oncology reps trying to reach the doctors and an increasing number of doctors joining institutions that severely restrict rep access."

Access to physicians overall has declined consistently since the first survey in 2008. In 2013, 45 percent of the prescribers placed significant restrictions on rep access, compared to 35 percent of prescribers one year ago and 23 percent in 2008.

AccessMonitor™ incorporates sales-call reports from more than 200 different U.S. pharmaceutical sales teams. The report examines how often approximately 325,000 physicians and other prescribers meet with pharmaceutical sales representatives who visit them.

Access varies across the country

Access to oncologists is challenging for oncology sales reps throughout the United States. However, it is most restricted
'/>"/>

SOURCE ZS Associates
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
2. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
3. Lilly Oncology To Disclose New Pipeline Data At ASCO 2012
4. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
5. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
6. Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting
7. Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan.
8. Agendia Announces Nine Studies in Breast and Colon Cancer for Presentation at 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO)
9. Marshall Edwards Announces First Cohort Of Patients Dosed In Phase I Clinical Trial Of Oncology Drug Candidate ME-344
10. Novocure™ to Present NovoTTF™ Therapy Data at the 2012 Annual Scientific Meeting of the American Society of Clinical Oncology
11. Elekta to Demonstrate Latest MOSAIQ OIS Innovations for Oncology Practices at 2012 ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... NEWTOWN, Pa. , July 6, 2015 /PRNewswire/ ... services and technology provider, today announced that it ... retention firm, MediciGroup ® , Inc. (Medici).  The ... Access to Patients, LLC.  Medici also provides a ... finds missing patients globally.  Together with Medici, ...
(Date:7/6/2015)... , July 6, 2015 Hologic, Inc. (NASDAQ: ... to release its financial results for the third quarter ... the market closes.  In conjunction with the release, management ... p.m. Eastern Time. Interested participants may listen ... the United States ) or 719-325-4804 (for international ...
(Date:7/6/2015)... N.J. and FARMINGTON, Conn. ... Inc. (NYSE MKT: PTN), a biopharmaceutical company developing ... diseases with significant unmet medical need and commercial ... a private placement of Series E warrants to ... Series F warrants to purchase 2,191,781 shares of ...
Breaking Medicine Technology:BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3Hologic to Announce Financial Results for the Third Quarter of Fiscal 2015 on Wednesday, July 29, 2015 2Palatin Technologies Completes $30 Million Financing 2Palatin Technologies Completes $30 Million Financing 3Palatin Technologies Completes $30 Million Financing 4Palatin Technologies Completes $30 Million Financing 5
... Inc. (RLI), a wholly owned subsidiary of Ranbaxy Laboratories ... and Drug Administration (FDA) has approved Absorica™, a novel, ... the treatment of severe recalcitrant nodular acne. Through a ... RLI is expected to launch Absorica™ in the U.S. ...
... 2012  Janssen Therapeutics, Division of Janssen Products, LP, ... (FDA) has issued a Complete Response letter for ... 800mg tablet of PREZISTA® (darunavir). PREZISTA is ... 400mg tablets -- for the treatment of human immunodeficiency ...
Cached Medicine Technology:Ranbaxy Announces U.S. FDA Approval of CIP-Isotretinoin NDA 2FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 2FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 3FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 4FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 5FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 6FDA Issues Complete Response Letter for 800mg PREZISTA® (darunavir) Tablet 7
(Date:7/6/2015)... ... July 06, 2015 , ... ... Spa industries, announces the return of its complimentary educational webinar series ... medical business leaders creates success for their clients through targeted marketing, sales, digital ...
(Date:7/6/2015)... ... 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics reached a ... at a CAGR of over 3.2 percent in the years to come to hit ... mainly spurred by an anticipated launch of a number of promising pipeline candidates and ...
(Date:7/6/2015)... ... , ... doTERRA, the leading global essential oils company, is pleased to announce ... the position as Director of the Hinckley Institute at the University of Utah, a ... Jowers states that he was ready for a new challenge, and out of many ...
(Date:7/6/2015)... ... ... Seedstock today announced Pierre Sleiman, founder and CEO of Go Green ... Conference – “Innovation and the Small Farmer” – to be held Nov. 3-4 San ... will explore solutions and methodologies that small farmers and entrepreneurs are developing to improve ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... MD Now, ... Monday, July 6. The newly constructed urgent care center will serve residents and visitors ... In addition to being MD Now’s 22nd South Florida location, the new facility will ...
Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3
... new research, Atkins diet-low carbohydrate diet can increase the risks ... the production of a fatty acid in the gut , ... acid butyrate, which protects against colorectal cancer, is produced by ... Rowett Research Institute, in Aberdeen, found that the widely ...
... the rule themselves - and certainly so when it comes ... local authorities have sent notices to the Delhi High Court, ... for breeding mosquitoes, the carrier of the dreaded dengue and ... field visits they have found mosquito breeding grounds in the ...
... launching Stop AIDS in Children, a campaign that calls for ... half a million new infant HIV infections that occur worldwide ... the leaders of the world's eight most powerful countries had ... for prevention of mother-to-child transmission (PMTCT) services in the developing ...
... The British government took a step Wednesday toward offering vaccinations ... a measure that could be carried out by late next ... recommended the use of vaccines to guard against the human ... cases of cervical cancer. ,The Department of Health ...
... her current rehab stint pretty 'serious' and doesn't want to 'mess ... Girls' star said that the actress will be in the rehab ... time frame for her stay due to her work schedule. ... We don't know how much longer because of her work schedule, ...
... dozens of nurses who had blocked a main road in front ... The nurses had set up camp in the street in ... ,An AFP reporter saw several units of police in ... security forces cleared the street itself, the nurses managed to continue ...
Cached Medicine News:Health News:Notice Sent to Courts Asking Them to Stop Courting Mosquitoes 2Health News:AIDS Charity AVERT Launches Stop AIDS in Children Campaign 2Health News:Girls Could Be Vaccinated Against Cervical Cancer in Britain 2Health News:Polish Police Break Up Nurses' Pay Protest 2
Inquire...
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
Inquire...
Medicine Products: